Breast Implants Linked to Rare Cancer Recalled

Textured breast implants made by Allergan that have been linked to an unusual cancer are being recalled in the United States at the request of the Food and Drug Administration (FDA), and will be requested to be recalled globally.

The disease is anaplastic large-cell lymphoma, a rare cancer of the immune system. The condition has occurred with implants placed for cosmetic breast enlargement and with those used for reconstruction after mastectomy for breast cancer. Though it is not breast cancer, it develops in tissue around the implant. In most cases, removing the implant and the scar tissue around it cures the cancer, but if it is not detected early enough it can spread and potentially kill patients.

Worldwide, 573 cases and 33 deaths from the cancer have been reported by the FDA, with 481 of the cases being attributed to Allergan Biocell implants. Of the 33 deaths, data showed that the type of implant was known in 13 cases, and in 12 of those cases the maker was Allergan.

The main symptoms of the lymphoma are usually swelling and fluid accumulation around the implant. If those symptoms occur, the fluid should be drained and tested for the cancer.

Compiled by Olivia Boyd, WI Intern

Show More

Related Articles

Leave a Reply

Back to top button

Subscribe today for free and be the first to have news and information delivered directly to your inbox.

By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Adblock Detected

Please consider supporting us by disabling your ad blocker
%d bloggers like this: